New research from Northeastern professor Alessandro Vespignani finds that the number of reported Zika cases in the U.S. may be just the tip of the iceberg due to widespread underreporting. The study also models the predicted spread of Zika across the Americas through 2017.
Professor John Engen helped develop a new hybrid technique to study how a critical HIV protein changes shape to allow infected cells to evade the immune system.
John de la Parra has a goal of using his love of plants to find new medicines from indigenous cultural practices and then bring in the full power of modern biotechnology to create a a controllable platform to create the medicines desperately needed for disease.
Side-channel attacks are an emerging threat to embedded systems. As a result, mathematics professor Aidong (Adam) Ding and colleagues are creating a tool that automatically corrects for side-channel weaknesses.
Derion Reid, Chemistry PhD candidate, sits down with the College of Science Graduate Program staff to talk about what it’s like to work and study at Northeastern University.
Hannah Powers had a very busy spring in Germany while on co-op at the University of Kaiserlautern.
Psychology professor Charles Hillman, a new member of Northeastern University’s College of Science faculty, has been appointed to the 2018 Physical Activity Guidelines Advisory Committee.
Nicholas Haubrich has been a busy man while on co-op. When he’s not working long hours on location, he’s traveling through Europe.
Associate dean and physics professor George Alverson received an award from CERN.
Boston is the apex of today’s biotechnology world. With over 250 companies in Boston, Cambridge, and surrounding suburbs, nearly every pharmaceutical company has a stake in Boston’s biotech network.